Innate and adaptive immunity in allergic airway disease.
Journal
Current opinion in allergy and clinical immunology
ISSN: 1473-6322
Titre abrégé: Curr Opin Allergy Clin Immunol
Pays: United States
ID NLM: 100936359
Informations de publication
Date de publication:
01 02 2022
01 02 2022
Historique:
pubmed:
30
11
2021
medline:
27
1
2022
entrez:
29
11
2021
Statut:
ppublish
Résumé
This article explores recent findings on the involvement of innate immunity in allergic airways disease, concentrating on allergic rhinitis. We speculate on the ways in which environmental influences act to initiate inflammation and on how these may have altered in recent decades. Improved understanding of the mechanisms involved may reveal future possibilities for therapy. The complex nature of immunity - both innate and acquired - in airways disease has implications for prevention and for therapy and requires further elucidation.
Identifiants
pubmed: 34840274
doi: 10.1097/ACI.0000000000000800
pii: 00130832-202202000-00003
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
10-15Informations de copyright
Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved.
Références
Scadding GK, Scadding GW. Innate and adaptive immunity: ILC2 and Th2 cells in upper and lower airway allergic diseases. J Allergy Clin Immunol Pract 2021; 9:1851–1857.
Bousquet J, Anto JM, Bachert C, et al. Allergic rhinitis. Nat Rev Dis Primers 2020; 6:95.
Zwickey H, Thompson B, 18 - Immune Function Assessment, Editor(s): Pizzorno JE, Murray MT, Textbook of Natural Medicine (Fifth Edition), Churchill Livingstone, 2020,157-165.e1. https://doi.org/10.1016/B978-0-323-43044-9.00018-2 . ( https://www.sciencedirect.com/science/article/pii/B9780323430449000182 )
McLean WH. The allergy gene: how a mutation in a skin protein revealed a link between eczema and asthma. F1000 Med Rep 2011; 3:2.
Cozener ZC, Cevhertas L, Nadeau K, et al. Environmental factors in epithelial barrier dysfunction. J Allergy Clin Immunol 2020; 145:1517–1528.
Liu YJ. Thymic stromal lymphopoietin: master switch for allergic inflammation. J Exp Med 2006; 203:269–273.
Nurieva RI, Liu X, Dong C. Yin-Yang of costimulation: crucial controls of immune tolerance and function. Immunol Rev 2009; 229:88–100.
Powe DG, Huskisson RS, Carney AS, et al. Mucosal T-cell phenotypes in persistent atopic and nonatopic rhinitis show an association with mast cells. Allergy 2004; 59:204–212.
Rondon C, Dona I, Lopez S, et al. Seasonal idiopathic rhinitis with local inflammatory response and specific IgE in absence of systemic response. Allergy 2008; 63:1352–1358.
Testera-Montes A, Salas M, Palomares F, et al. Eguiluz-Gracia I local respiratory allergy: from rhinitis phenotype to disease spectrum. Front Immunol 2021; 12:691964.
Zheng H, Zhang Y, Pan J, et al. The role of type 2 innate lymphoid cells in allergic diseases. Front Immunol 2021; 12:586078.
van Tongeren J, Golebski K, Van Egmond D, et al. Synergybetween TLR-2 and TLR-3 signaling in primary human nasal epithelial cells. Immunobiology 2015; 220:445–451.
Radman M, Golshiri A, Shamsizadeh A, et al. Toll-like receptor 4 plays significant roles duringallergic rhinitis. Allergol Immunopathol (Madr) 2015; 43:416–420.
Karta MR, Broide DH, Doherty TA. Insights into group 2 innate lymphoid cells in human airway disease. Curr Allergy Asthma Rep 2016; 16:8.
Vivier E, Artis D, Colonna M, et al. Innate lymphoid cells: 10 years on. Cell 2018; 174:1054–1066.
Lloyd CM, Snelgrove RJ. Type 2 immunity: expanding our view. SciImmunol 2018; 3:eaat1604.
Martinez-Gonzalez I, Mathä L, Steer CA, et al. Allergen-experienced Group 2 innate lymphoid cells acquire memory-like properties and enhance allergic lung inflammation. Immunity 2016; 45:198–208.
Gold MJ, Antignano F, Halim TY, et al. Group 2 innate lymphoid cells facilitate sensitization to local, but not systemic, TH2-inducing allergen exposures. J Allergy Clin Immunol 2014; 133:1142–1148.
Licona-Limon P, Kim LK, Palm NW, Flavell RA. TH2, allergy and group 2 innate lymphoid cells. Nat Immunol 2013; 14:536–542.
Asaka D, Yoshikawa M, Nakayama T, et al. Elevated levels of interleukin-33 in the nasal secretions of patients with allergic rhinitis. Int Arch Allergy Immunol 2012; 158: (Suppl 1): 47–50.
Liu G, Liu F. Advances of IL-33/ST2 signaling pathway in allergic rhinitis [in Chinese]. Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 2020; 34:565–568. Chinese.
Stevens WW, Schleimer RP, Kern RC. Chronic rhinosinusitis with nasal polyps. J Allergy Clin Immunol Pract 2016; 4:565–572.
Beasley R, Keil U, Von Mutius E, Pearce N. Worldwide variation in prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and atopic eczema: ISAAC. Lancet 1998; 351:1225–1232.
Strachan DP. Hay fever, hygiene, and household size. Br Med J 1989; 299:1259–1260.
Strachan DP, Ait-Khaled N, Foliaki S, et al. Siblings, asthma, rhinoconjunctivitis and eczema: a worldwide perspective from the International Study of Asthma and Allergies in Childhood. Clin Exp Allergy 2015; 45:126–136.
Bisgaard H, Li N, Bonnelykke K, et al. Reduced diversity of the intestinal microbiota during infancy is associated with increased risk of allergic disease at school age. J Allergy Clin Immunol 2011; 128:646–652. e5.
Penders J, Thijs C, van den Brandt PA, et al. Gut microbiota composition and development of atopic manifestations in infancy: the KOALA birth cohort study. Gut 2007; 56:661–667.
Adlerberth I, Strachan DP, Matricardi PM, et al. Gut microbiota and development of atopic eczema in 3 European birth cohorts. J Allergy Clin Immunol 2007; 120:343–350.
Johansson MA, Sjogren YM, Persson JO, et al. Early colonization with a group of Lactobacilli decreases the risk for allergy at five years of age despite allergic heredity. PLoS One 2011; 6:e23031.
Lambrecht BN, Hammad H. The immunology of asthma. Nat Immunol 2015; 16:45–56.
Muehling LM, Heymann PW, Wright PW, et al. Human TH1 and TH2 cells targeting rhinovirus and allergen co-ordinately promote allergic asthma. J Allergy Clin Immunol 2020; 146:555–570.
Wise SK, Lin SY, Toskala E, et al. International Consensus Statement on allergy and rhinology. Allergic Rhinitis IFAR 2018; 8:108–352.
Waite KJ. Blackley and the development of hay fever as a disease of civilization in the nineteenth century. Med Hist 1995; 39:186–196.
Butland BK, Strachan DP, Lewis S, et al. Investigation into the increase in hay fever and eczema at age 16 observed between the 1958 and 1970 British birth cohorts. BMJ 1997; 315:717–721.
Lewis SA, Britton JR. Consistent effects of high socioeconomic status and low birth order, and the modifying effect of maternal smoking on the risk of allergic disease during childhood. Respir Med 1998; 92:1237–1244.
Braback L, Hjern A, Rasmussen F. Social class in asthma and allergic rhinitis: a national cohort study over three decades. Eur Respir J 2005; 26:1064–1068.
Bergmann RL, Edenharter G, Bergmann KE, et al. Socioeconomic status is a risk factor for allergy in parents but not in their children. Clin Exp Allergy 2000; 30:1740–1745.
Matheson MC, Walters EH, Simpson JA, et al. Relevance of the hygiene hypothesis to early vs. late onset allergic rhinitis. Clin Exp Allergy 2009; 39:370–378.
Pierangeli I, Nieuwenhuijsen MJ, Cirach M, Rojas-Rueda D. Health equity and burden of childhood asthma - related to air pollution in Barcelona. Environ Res 2020; 186:109067doi: 10.1016/j.envres.2019.109067. [Epub ahead of print].
doi: 10.1016/j.envres.2019.109067.
Khreis H, Cirach M, Mueller N, de Hoogh K, et al. Outdoor air pollution and the burden of childhood asthma across Europe. Eur Respir J 2019; 54:1802194doi: 10.1183/13993003.02194-2018.
doi: 10.1183/13993003.02194-2018
Burte E, Leynaert B, Marcon A, Bousquet J, et al. Long-term air pollution exposure is associated with increased severity of rhinitis in 2 European Cohorts. J Allergy Clin Immunol 2020; 145:834–842.
Annesi-Maesano I, Rouve S, Desqueyroux H, et al. Grass pollen counts, air pollution levels and allergic rhinitis severity. Int Arch Allergy Immunol 2012; 158:397–404.
Sedghy F, Varasteh AR, Sankian M, Moghadam M. Interaction between air pollutants and pollen grains: the role on the rising trend in allergy. Rep Biochem Mol Biol 2018; 6:219–224.
Tubita V, Callejas-Díaz B, Roca-Ferrer J, et al. Role of microRNAs in inflammatory upper airway diseases. Allergy 2021; 76:1967–1980.
Chen R-F, Huang H-C, Ou C-Y, et al. microRNA-21 expression in neonatal blood associated with antenatal immunoglobulin e production and development of allergic rhinitis. Clin Exp Allergy 2010; 40:1482–1490.
Shaoqing YU, Ruxin Z, Guojun L, et al. Microarray analysis of differentially expressed microRNAs in allergic rhinitis. Am J Rhinol Allergy 2011; 25:e242–e246.
Vigorito E, Kohlhaas S, Lu D, Leyland R. miR-155: an ancient regulator of the immune system. Immunol Rev 2013; 253:146–157.
Zhu Y-Q, Liao B, Liu Y-H, et al. MicroRNA-155 plays critical effects on Th2 factors expression and allergic inflammatory response in type-2 innate lymphoid cells in allergic rhinitis. Eur Rev Med Pharmacol Sci 2019; 23:4097–4109.
Zhu Y-Q, Liu Y, Zhu X, et al. Upregulation of miR-155 regulates group 2 innate lymphoid cells by targeting c-maf in allergic rhinitis. Eur J Pharmacol 2020; 887:173564.
Luo X, Zeng Q, Yan S, et al. MicroRNA-375-mediated regulation of ILC2 cells through TSLP in allergic rhinitis. World Allergy Organ J 2020; 13:100451.